Literature DB >> 34306334

Circular RNA circNEURL4 inhibits cell proliferation and invasion of papillary thyroid carcinoma by sponging miR-1278 and regulating LATS1 expression.

Wei Ding1, Ying Shi1, Hong Zhang1.   

Abstract

Circular RNAs (circRNA) are found to be closely associated with cancers as their possibility as "sponges" to miRNAs, thus liberating the downstream target mRNA. However, deep research is still needed to study the function of circRNA in papillary thyroid carcinoma (PTC). Here, we sought to explore new circRNA which could play an important role in the development of PTC. We filtered candidate circRNAs based on microarray data from public database and verified the result using qRT-PCR. We performed CCK8 assay, colony formation assay, apoptosis assay, transwell assays, and xenograft experiments to explore the function of selected circRNA on PTC. We predicted the miRNA targets of the circRNA and the target gene of miRNA through bioinformatic analysis and validated the target by mutant experiments. And by the use of overexpression experiments, knockdown experiments, and the functional assays mentioned above, we figured out the pathway behind the selected circRNA. Based on our data, we found that circNEURL4 was significantly decreased in the PTC samples and lower expression of circNEURL4 was closely associated with a poor prognosis of patients with PTC. Then, we proved that circNEURL4 could inhibit cell proliferation and invasion of PTC in vivo and in vitro. Furthermore, we demonstrated that circNEURL4 may binding to miR-1278 and thus indirectly improving the expression of LATS1. Our findings revealed that circNEURL4 may probably serve as a diagnostic marker to predict PTC patients' prognosis and a possible therapeutic target to PTC via miR-1278/LATS1 axis. AJTR
Copyright © 2021.

Entities:  

Keywords:  LATS1; Papillary thyroid carcinoma; cell invasion; cell proliferation; circNEURL4; miR-278

Year:  2021        PMID: 34306334      PMCID: PMC8290797     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  31 in total

1.  Thyroid cancer in Denmark 1943-2008, before and after iodine supplementation.

Authors:  M Blomberg; U Feldt-Rasmussen; K K Andersen; S K Kjaer
Journal:  Int J Cancer       Date:  2012-03-20       Impact factor: 7.396

2.  Amphiphilic silicones to reduce the absorption of small hydrophobic molecules.

Authors:  Manuel Quiñones-Pérez; Ruben J Cieza; Bryan Khai D Ngo; Melissa A Grunlan; Maribella Domenech
Journal:  Acta Biomater       Date:  2020-11-30       Impact factor: 8.947

3.  Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease.

Authors:  William D T Kent; Stephen F Hall; Phillip A Isotalo; Robyn L Houlden; Ralph L George; Patti A Groome
Journal:  CMAJ       Date:  2007-11-20       Impact factor: 8.262

4.  Western blot: technique, theory, and trouble shooting.

Authors:  Tahrin Mahmood; Ping-Chang Yang
Journal:  N Am J Med Sci       Date:  2012-09

5.  Microarray profiling of circular RNAs in human papillary thyroid carcinoma.

Authors:  Nianchun Peng; Lixin Shi; Qiao Zhang; Ying Hu; Nanpeng Wang; Hui Ye
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

6.  Circular RNA CircMAP3K5 Acts as a MicroRNA-22-3p Sponge to Promote Resolution of Intimal Hyperplasia Via TET2-Mediated Smooth Muscle Cell Differentiation.

Authors:  Zhi Zeng; Luoxing Xia; Shunyang Fan; Junmeng Zheng; Jinhong Qin; Xuejiao Fan; Yunfeng Liu; Jun Tao; Yingying Liu; Kang Li; Zhenwei Ling; Yun Bu; Kathleen A Martin; John Hwa; Renjing Liu; Wai Ho Tang
Journal:  Circulation       Date:  2020-11-19       Impact factor: 29.690

Review 7.  Circular RNAs are a novel type of non-coding RNAs in ROS regulation, cardiovascular metabolic inflammations and cancers.

Authors:  Fatma Saaoud; Charles Drummer I V; Ying Shao; Yu Sun; Yifan Lu; Keman Xu; Dong Ni; Xiaohua Jiang; Hong Wang; Xiaofeng Yang
Journal:  Pharmacol Ther       Date:  2020-10-24       Impact factor: 12.310

8.  Overexpression of lncRNA PIK3CD-AS1 promotes expression of LATS1 by competitive binding with microRNA-566 to inhibit the growth, invasion and metastasis of hepatocellular carcinoma cells.

Authors:  Wei Song; Jingjing Zhang; Jianbo Zhang; Miaomiao Sun; Qingxin Xia
Journal:  Cancer Cell Int       Date:  2019-10-09       Impact factor: 5.722

Review 9.  Circular RNAs Are Regulators of Diverse Animal Transcriptomes: One Health Perspective.

Authors:  Dora Zucko; Kathleen Boris-Lawrie
Journal:  Front Genet       Date:  2020-09-18       Impact factor: 4.599

10.  Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma.

Authors:  Shuheng Bai; YinYing Wu; Yanli Yan; Shuai Shao; Jiangzhou Zhang; Jiaxin Liu; Beina Hui; Rui Liu; Hailin Ma; Xiaozhi Zhang; Juan Ren
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379

View more
  5 in total

1.  Hsa_circ_0000285 contributes to gastric cancer progression by upregulating FN1 through the inhibition of miR-1278.

Authors:  Xue Wang; Mao Tan; He Huang; Yanlei Zou; Mengqiao Wang
Journal:  J Clin Lab Anal       Date:  2022-05-09       Impact factor: 3.124

2.  Sevoflurane Suppresses the Growth, Metastasis, and Invasion of Endometrial Carcinoma Cells via miR-195-5p/JAK2 Axis.

Authors:  Guowei Fu; Junlan Huang; Zhouquan Wu; Lin Zhao
Journal:  Comput Math Methods Med       Date:  2022-02-22       Impact factor: 2.238

3.  Circ_0005918 Sponges miR-622 to Aggravate Intervertebral Disc Degeneration.

Authors:  Yan Cui; Xintong Zhao; Yangang Wu
Journal:  Front Cell Dev Biol       Date:  2022-07-08

Review 4.  Function and Clinical Significance of Circular RNAs in Thyroid Cancer.

Authors:  Xuelin Yao; Qiu Zhang
Journal:  Front Mol Biosci       Date:  2022-07-22

Review 5.  A Review and In Silico Analysis of Tissue and Exosomal Circular RNAs: Opportunities and Challenges in Thyroid Cancer.

Authors:  Eman A Toraih; Mohammad H Hussein; Manal S Fawzy; Emad Kandil
Journal:  Cancers (Basel)       Date:  2022-09-28       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.